ATE172201T1 - Morphinan-derivate und medizinische verwendung - Google Patents

Morphinan-derivate und medizinische verwendung

Info

Publication number
ATE172201T1
ATE172201T1 AT93902520T AT93902520T ATE172201T1 AT E172201 T1 ATE172201 T1 AT E172201T1 AT 93902520 T AT93902520 T AT 93902520T AT 93902520 T AT93902520 T AT 93902520T AT E172201 T1 ATE172201 T1 AT E172201T1
Authority
AT
Austria
Prior art keywords
medical uses
nch3
morphinane derivatives
morphinane
derivatives
Prior art date
Application number
AT93902520T
Other languages
English (en)
Inventor
Hiroshi Nagase
Koji Kawai
Kuniaki Kawamura
Jun Hayakawa
Takashi Endo
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of ATE172201T1 publication Critical patent/ATE172201T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fertilizers (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Saccharide Compounds (AREA)
AT93902520T 1992-01-23 1993-01-22 Morphinan-derivate und medizinische verwendung ATE172201T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1011592 1992-01-23
JP29430892 1992-11-02

Publications (1)

Publication Number Publication Date
ATE172201T1 true ATE172201T1 (de) 1998-10-15

Family

ID=26345314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902520T ATE172201T1 (de) 1992-01-23 1993-01-22 Morphinan-derivate und medizinische verwendung

Country Status (15)

Country Link
US (2) US6323212B1 (de)
EP (2) EP0577847B1 (de)
JP (1) JP2525552B2 (de)
KR (1) KR970011390B1 (de)
AT (1) ATE172201T1 (de)
AU (2) AU666702B2 (de)
CA (1) CA2105072C (de)
DE (1) DE69321525T2 (de)
DK (1) DK0577847T3 (de)
ES (1) ES2121988T3 (de)
FI (1) FI106126B (de)
NO (1) NO302755B1 (de)
NZ (1) NZ246687A (de)
TW (1) TW332814B (de)
WO (1) WO1993015081A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
WO1995001178A1 (en) * 1993-06-30 1995-01-12 Toray Industries, Inc. Antitussive
WO1995003307A1 (en) * 1993-07-19 1995-02-02 Toray Industries, Inc. Brain cell protective
JP3843456B2 (ja) * 1993-07-23 2006-11-08 東レ株式会社 モルヒナン誘導体および医薬用途
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
DE19602961A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Dihydromorphinderivate, Verfahren zu deren Herstellung und deren Verwendung
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
EP0829481A1 (de) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan-Hydroxamsäure-Derivate
EP1327444B1 (de) * 1996-11-25 2005-03-23 Toray Industries, Inc. Mittel gegen Juckreiz
EP0915094B1 (de) * 1997-03-27 2007-11-07 Toray Industries, Inc. Morphinanderivate und ihre medizinische Anwendung
ATE268178T1 (de) * 1997-07-11 2004-06-15 Toray Industries Stabile medizinische zusammenstellungen die 4,5- epoxymorphinanderivate enthalten
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
BR9810706A (pt) * 1997-07-14 2000-08-08 Adolor Corp Processo para a prevenção ou tratamento do prurido em um mamìfero em necessidade de tal prevenção ou tratamento
WO1999005146A1 (en) * 1997-07-25 1999-02-04 Toray Industries, Inc. Hyponatremia remedies
US6583151B2 (en) 1997-09-02 2003-06-24 Toray Industries, Inc. Remedies for drug addiction
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
CA2383146C (en) * 1999-08-24 2010-11-16 Hiroshi Nagase Therapeutic agent for neuropathic pain and neuropathic pain animal model
NZ519897A (en) * 1999-12-03 2004-02-27 Iouri Malov Electroretinogram (ERG) using image segments which stimulate output signals with very little cross-correlation
WO2001074819A1 (en) * 2000-04-03 2001-10-11 Toray Industries, Inc. Analgesics containing morphinan n-oxide derivatives as the active ingredient
CA2442423C (en) 2001-03-30 2009-11-03 Toray Industries, Inc. Therapeutic drug for psychoneurotic disorders
WO2002080918A1 (en) * 2001-04-02 2002-10-17 Toray Industries, Inc. Remedial or prophylactic agent for frequent urination or urinary incontinence
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CN1653050B (zh) 2002-05-17 2013-04-24 詹肯生物科学公司 阿片和阿片样化合物及其用途
KR101060629B1 (ko) 2002-10-09 2011-08-31 도레이 카부시키가이샤 빈뇨 혹은 요실금의 치료 또는 예방제 및 함질소 환상치환기를 갖는 몰피난 유도체
US8017622B2 (en) * 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CA2527693C (en) * 2003-06-04 2018-09-18 Harry G. Brittain Polymorphic forms of naltrexone
JP5266492B2 (ja) * 2004-05-28 2013-08-21 ヒューマン バイオモレキュラル リサーチ インスティテュート 代謝安定性鎮痛薬、疼痛薬物療法及び他の物質の合成
TW200621785A (en) * 2004-11-04 2006-07-01 Toray Industries Analgesic
DK1873158T3 (en) * 2005-04-06 2016-06-27 Toray Industries Crystals of a morphinan derivative and process for preparing the same
ES2307352B1 (es) * 2005-04-12 2009-09-18 Bti, I+D, S.L. Implante dental y piezas destinadas a ser conectadas a un implante dental, y la conexion interna entre el implante dental y cada pieza.
ES2629766T3 (es) 2006-04-21 2017-08-14 Nektar Therapeutics Reducción estereoselectiva de una morfinona
JP5251870B2 (ja) 2007-04-24 2013-07-31 東レ株式会社 ジスキネジアの治療または予防剤
JP5099127B2 (ja) 2007-04-26 2012-12-12 東レ株式会社 ４，５−エポキシモルヒナン誘導体を含有する安定な固形製剤
CN101778632B (zh) * 2007-06-22 2012-02-29 东丽株式会社 综合失调症的治疗或预防药
MX2010003660A (es) 2007-10-05 2010-08-10 Toray Industries Agente para aliviar problemas de la piel que comprende un derivado de morfinano o una sal de adicion de acido, farmacologicamente aceptable del mismo como ingrediente activo.
EP2252150B1 (de) * 2008-02-14 2018-04-11 Alkermes, Inc. Selektive opioidverbindungen
US8609682B2 (en) 2008-07-11 2013-12-17 Regents Of The University Of Minnesota Analgesic agents
TR201802379T4 (tr) 2008-10-24 2018-03-21 Toray Industries 4,5-epoksimorfinan türevi içeren stabil tablet.
JP2012518651A (ja) * 2009-02-23 2012-08-16 マリンクロッド インコーポレイテッド （＋）−モルフィナニウムｎ−オキシドおよびそれらの生成方法
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010096788A1 (en) * 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-morphinanium quaternary salts and processes for their production
WO2010096791A1 (en) * 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010144641A1 (en) * 2009-06-11 2010-12-16 Mallinckrodt Inc. Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer
US8471023B2 (en) * 2009-06-11 2013-06-25 Mallinckrodt Llc Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
MX362830B (es) 2010-01-29 2019-02-14 Toray Industries Agente terapeutico o profilactico para enfermedades del tracto biliar.
WO2011154826A1 (en) 2010-06-11 2011-12-15 Rhodes Technologies Process for n-dealkylation of tertiary amines
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
WO2012008984A1 (en) 2010-07-16 2012-01-19 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
ES2632932T3 (es) * 2010-10-19 2017-09-18 Memorial Sloan-Kettering Cancer Center Derivados 6-amido de 4,5a-epoximorfinanos para el tratamiento del dolor
EP2671585B1 (de) 2011-01-31 2016-07-13 Toray Industries, Inc. (-)-17-(Cyclopropylmethyl)-3,14ß-Dihydroxy-4,5a-Epoxy-6ß-[N-Methyl-trans-3-(3-Furyl)acrylamido]Morphinan zur Verwendung bei der Behandlung oder Vorbeugung von Krebskachexie
MX2013013634A (es) 2011-06-09 2013-12-12 Mallinckrodt Llc Aminacion reductiva de 6-ceto-morfinanos por transfrencia catalitica de hidrogeno.
KR20140063763A (ko) 2011-09-08 2014-05-27 말린크로트 엘엘씨 중간체를 단리하지 않는 알칼로이드의 제조 방법
CA2882132C (en) 2012-08-16 2021-07-06 The Scripps Research Institute Kappa opioid ligands
TWI449704B (zh) * 2013-04-26 2014-08-21 Everlight Chem Ind Corp 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物
ES2784690T3 (es) 2013-12-05 2020-09-29 Univ Bath Nuevos compuestos opioides y sus usos
JP2015166331A (ja) * 2014-05-14 2015-09-24 遼東化学工業株式会社 ナルフラフィンの結晶およびその製造方法
JPWO2016152953A1 (ja) * 2015-03-24 2018-01-11 東レ株式会社 モルヒナン誘導体及びその医薬用途
CA3241654A1 (en) 2015-04-30 2016-11-03 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
US10377763B2 (en) 2015-10-29 2019-08-13 University Of Tsukuba Morphinan derivative and medical usage thereof
US11529340B2 (en) 2016-03-22 2022-12-20 Regents Of The University Of Minnesota Combination for treating pain
WO2017200970A1 (en) * 2016-05-19 2017-11-23 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
JP6814470B2 (ja) 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
CN112004538A (zh) * 2018-02-27 2020-11-27 德尔宝股份有限公司 小分子治疗剂化合物的组合物
DK3761982T3 (da) 2018-03-08 2025-01-02 Victoria Link Ltd Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme
CN113614089B (zh) * 2019-03-29 2024-08-20 人福医药美国公司 可用于治疗医学病症的新型吗啡喃
WO2021007366A1 (en) * 2019-07-08 2021-01-14 St. Louis College Of Pharmacy G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
AU2020360928A1 (en) 2019-09-30 2022-04-14 Nippon Chemiphar Co., Ltd. Azepan derivative
US20240139176A1 (en) 2019-10-24 2024-05-02 Toray Industries, Inc. Methods of treating or preventing cachexia
AU2021298446A1 (en) * 2020-06-30 2023-02-09 Toray Industries, Inc. Ameliorating agent or prophylactic agent for muscle weakness symptom in disease or syndrome associated with metabolic disorder
CN115181109B (zh) * 2021-04-02 2024-06-04 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
CA3216667A1 (en) 2021-04-23 2022-10-27 Toray Industries, Inc. Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc Urea derivatives which can be used to treat cancer
CN115960108A (zh) * 2021-10-09 2023-04-14 山东新时代药业有限公司 一种无定型盐酸纳呋拉啡及其制备方法
WO2023190665A1 (ja) * 2022-03-29 2023-10-05 東レ株式会社 モルヒナン誘導体及びその医薬用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236851A (en) * 1966-02-22 Unsaturated morphinan derivatives
NL290054A (de)
DE622231C (de) * 1934-03-09 1935-11-23 Hermann Fischer Dr Verfahren zur Herstellung von Diacetylmorphin
GB864107A (en) 1958-09-10 1961-03-29 Albert Boehringer Morphine derivatives
GB919311A (en) 1958-10-29 1963-02-20 T & H Smith Ltd Derivatives of 14-hydroxycodeine and their preparation
DE2254298A1 (de) * 1972-11-06 1974-05-16 Boehringer Sohn Ingelheim Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
US4362870A (en) 1980-01-16 1982-12-07 Regents Of The University Of Minnesota Selective opioid receptor alkylating agents
JPS574991A (en) 1980-06-10 1982-01-11 Sankyo Co Ltd Cyclopropylmethylnormorphine-6-sulfuric ester
US4401672A (en) 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4767718A (en) * 1984-06-18 1988-08-30 Southern Illinois University Foundation Fluorescent opioid reagents and methods of use thereof in the detection of opioid receptors
IN163125B (de) 1985-01-08 1988-08-13 Alkaloida Vegyeszeti Gyar
DE3617182A1 (de) 1985-05-23 1986-11-27 Sandoz-Patent-GmbH, 79539 Lörrach Morphinan-derivate
HU196376B (en) 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
US4806556A (en) 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4730048A (en) 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JPH01149788A (ja) 1987-12-08 1989-06-12 Chugai Pharmaceut Co Ltd 新規なモルヒネ誘導体
FR2636330B1 (fr) 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
KR900009650A (ko) 1988-12-21 1990-07-05 사노하지메 신규 모르핀 유도체
US5219861A (en) * 1988-12-21 1993-06-15 Chugai Seiyaku Kabushiki Kaisha 6 β-Thiomorphine derivatives
US5258386A (en) * 1991-06-05 1993-11-02 The United States Of America As Represented By The Secretary Of The Army (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
WO1995001178A1 (en) * 1993-06-30 1995-01-12 Toray Industries, Inc. Antitussive

Also Published As

Publication number Publication date
DE69321525D1 (de) 1998-11-19
CA2105072C (en) 1998-07-28
FI934144L (fi) 1993-09-22
US6323212B1 (en) 2001-11-27
FI934144A0 (fi) 1993-09-22
CA2105072A1 (en) 1993-07-24
DE69321525T2 (de) 1999-03-04
NO933376L (no) 1993-09-23
AU686483B2 (en) 1998-02-05
EP0577847A4 (de) 1994-12-07
NZ246687A (en) 1996-12-20
FI106126B (fi) 2000-11-30
AU666702B2 (en) 1996-02-22
NO302755B1 (no) 1998-04-20
WO1993015081A1 (en) 1993-08-05
EP0577847B1 (de) 1998-10-14
US6277859B1 (en) 2001-08-21
JPH08502275A (ja) 1996-03-12
TW332814B (en) 1998-06-01
EP0846694A1 (de) 1998-06-10
AU4067195A (en) 1996-03-07
EP0577847A1 (de) 1994-01-12
JP2525552B2 (ja) 1996-08-21
AU3367193A (en) 1993-09-01
ES2121988T3 (es) 1998-12-16
DK0577847T3 (da) 1999-06-23
NO933376D0 (no) 1993-09-22
KR970011390B1 (ko) 1997-07-10

Similar Documents

Publication Publication Date Title
ATE172201T1 (de) Morphinan-derivate und medizinische verwendung
NO941101D0 (no) Quinazolin-derivater
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
ATE129498T1 (de) Kondensierte heterozyklische verbindungen, ihre herstellung und verwendung.
ATE247654T1 (de) Neue heterozyklische verbindungen
DE69428977D1 (de) Arzneimittel gegen Parkinsonsche Krankheit
FI943142A0 (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
DE69505470D1 (de) Pyrrolocarbazol
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
DK147588A (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
FI906021A0 (fi) Oxetanderivat, framstaellning av dessa samt anvaendning som svampmotverkande eller foerstoerande aemnen.
ATE55057T1 (de) Zentralwirkende muskelrelaxante.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
NO890996D0 (no) Fremgangsmaate for fremstilling av cefemforbindelser.
JPS56131571A (en) Novel hetero ring substituted carboxyamide and methyl amine compound
IT1204960B (it) Composti dotati di attivita' antiallergica
IT1204959B (it) Composti dotati di attivita' antiallergica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification